Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
kazakhstan
100%
data
79%
patients
54%
mortality
44%
populations
43%
diseases
37%
epidemiology
36%
comparative evaluations
23%
aggregation
18%
kidneys
17%
surveillance
17%
reviews
17%
hemorrhage
15%
hospitals
15%
females
12%
dialysis
11%
levels
11%
surgery
11%
males
11%
screening
10%
risks
10%
public health
10%
interventions
9%
hypertension
9%
tuberculosis
8%
bone joints
8%
recommendations
8%
peaks
8%
doses
8%
pneumonia
8%
pcr
8%
covid-19
8%
hemoglobin
8%
erythropoietin
8%
breasts
8%
cancer
8%
ischemia
8%
death
6%
control
6%
women
6%
hazards
6%
income
5%
evaluation
5%
sex
5%
Keyphrases
Kazakhstan
54%
Mortality Rate
24%
Incidence Rate
22%
Population Health Surveillance
17%
Intracerebral Hemorrhage
17%
Subarachnoid Hemorrhage
17%
Administrative Health Data
17%
Population Health Science
17%
Epidemiology
14%
Acute Ischemic Stroke
13%
Administrative Healthcare Data
11%
Discharge Status
11%
Stroke Patients
11%
Dialysis Patients
9%
Electronic Health
8%
Equivalency
8%
Real-world Clinical Practice
8%
Biosimilar
8%
Knee Osteoarthritis
8%
Early Intervention
8%
Impact of Screening
8%
Analytic Approach
8%
Centers for Disease Control
8%
Medical Big Data
8%
Disease Prevention
8%
Faculty Development
8%
Chronic Kidney Disease
8%
Early Identification
8%
Dialysis
8%
End-stage Renal Disease Patients
8%
Scoping Review
8%
Disability-adjusted Life Years
8%
Intervention Program
8%
Erythropoiesis-stimulating Agents
8%
Rate-based
8%
Regional Burden
8%
Electronic Health Systems
7%
Admission Status
6%
Registry Data
6%
Descriptive Statistics
6%
Survival Probability
6%
Hospital Admission
6%
Developing Countries
6%
Medicine and Dentistry
Mortality Rate
39%
Prevalence
35%
Cohort Effect
32%
Health System
19%
Apoplexy
17%
Subarachnoid Hemorrhage
14%
Brain Ischemia
14%
Cerebral Hemorrhage
14%
Public Health
11%
Chronic Kidney Disease
8%
Knee Osteoarthritis
8%
Biosimilar
8%
End Stage Renal Disease
8%
Hospital Mortality
8%
Disease Epidemiology
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
COVID-19
8%
Disability Adjusted Life Years
8%
Analeptic
8%
Polymerase Chain Reaction
8%
Gynecological Surgery
8%
Erythropoietin
8%
Breast Cancer
8%
Survival Rate
7%
Urban Population
5%
Hazard Ratio
5%